* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Volume 4, Supplement 1
Pharmaceutical industry wikipedia , lookup
Prescription costs wikipedia , lookup
Discovery and development of neuraminidase inhibitors wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
CCR5 receptor antagonist wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Theralizumab wikipedia , lookup
Discovery and development of HIV-protease inhibitors wikipedia , lookup
Discovery and development of non-nucleoside reverse-transcriptase inhibitors wikipedia , lookup
Discovery and development of integrase inhibitors wikipedia , lookup
Abstract 01 Approaches towards HIV-1 Eradication: Harnessing Cellular Restrictions M Stevenson University of Massachusetts Medical School, Worcester, MA, USA The replication of primate lentiviruses is dependent upon their ability to commandeer cellular factors at various stages in the replication cycle. Research over the past several years however, has revealed the presence of âcellular restrictionsâ that potently antagonize viral replication. For example, the Apobec 3 proteins are cytidine deaminases that compromise the formation and integrity of viral cDNA while Bst2/ tetherin prevents detachment of budding viruses from the surface of the infected cell. In order to counteract these restrictions, primate lentiviruses have evolved accessory proteins: the Vif protein targets Apobec 3 for proteasomal destruction while Vpu mislocalizes Bst2/tetherin away from sites of virus budding. We have recently obtained evidence for a novel restriction that is expressed in cells of macrophage lineage. This restriction potently antagonizes the replication of primate lentiviruses including HIV-1/2 and SIV as well as retroviruses such as MLV. We have evidence that this restriction is counteracted by the viral accessory proteins Vpx/ Vpr. These proteins commandeer a damaged DNA response protein (DDB1) to target the restriction to the proteasome. We have further obtained evidence that this restriction dictates the cell cycle dependence of lentivirus and retrovirus infection. Therefore when the restriction is neutralized, macrophages, which are normally refractory to MLV infection, are rendered permissive to MLV transduction. With a view to targeting accessory proteins for drug discovery, we have identified small molecule inhibitors of HIV-1 Vif. These Vif antagonists exhibit antiviral effects only in cells that express Apobec 3 proteins and increase the extent of cytidine deamination in nascent viral cDNA. Given our increasing understanding of the HIV DART 2008 - Frontiers in Drug Development for Antiretroviral Therapies function of the viral accessory proteins, they remain highly attractive targets for therapeutic intervention in HIV/AIDS. Abstract 02 Understanding HIV Maturation using Electron Cryotomography ER Wright1, JB Schooler1, HJ Ding1, C Kieffer2, C Fillmore2, WI Sundquist2, and GJ Jensen1 1 Division of Biology, California Institute of Technology, Pasadena, CA, USA; 2 Department of Biochemistry, University of Utah, Salt Lake City, UT, USA BACKGROUND: HIV maturation is a dynamic process, which occurs once the virus buds and is released from the infected cell. The unprocessed Gag polyprotein is composed of polypeptide segments, termed MA, CA, SP1, NC, SP2, and p6 that are arranged radially, with the N-terminal MA region at the membrane and the C-terminal NC-SP2-p6 region nearest the center [1, 2]. Maturation involves the proteolytic processing of Gag and Gag-Pol polyproteins by protease (PR). During maturation, MA remains bound to the membrane, while the processed CA subunits condense to form a central conical capsid that encases NC, the RNA genome, and other viral enzymes. The structures of nearly every component of HIV have been determined, but it is still unclear how individual subunits come together to form the intact virion. We are studying the maturation process of HIV-1 by electron cryotomography (cryo-ET) in order to understand the structural changes that occur within the virus. METHODS: HIV-1 virions were made non-infectious and/or halted in the immature state by the inactivation of the proteins PR, RT, and RNase H [3, 4]. Solutions of the purified HIV-1 virions were flash-frozen onto EM grids in liquid ethane. The frozen-hydrated grids were imaged in a 300 kV âG2 Polaraâ FEI TEM under low dose conditions. Single and dual-axis tilt series were collected using the predictive UCSF tomography package [5]. All images were energy-filtered, recorded 3